New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Once I hit middle age, I became ruthless about preserving the ...
Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Illumina exhibits better profitability ratios than many of its peers, which indicates that the company could continue to invest in its operations. In Q3 2025, ILMN raised its EPS to $4.65-$4.75, ...
Illumina’s revenue was flat for the third quarter as the sequencing giant continues to deal with headwinds from a China sales ban. The $1.08 billion it brought in for the third quarter was, however, ...
“Illumina’s…presentations and product descriptions revealed a workflow that infringed on the ‘607, ‘138, ‘505, and ‘487 patents, 10x Genomics and Prognosys Biosciences argued.” On October 21, 10x ...
Oct 21 (Reuters) - Biotech company 10x Genomics (TXG.O), opens new tab filed two lawsuits against rival Illumina (ILMN.O), opens new tab in Delaware federal court on ...
"Illumina has inflicted substantial harm on Element, resulting in lost sales, diminished market share, and reduced profits," counsel for DNA-sequencing company Element Biosciences Inc. alleged in an ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — A year ago, Illumina CEO Jacob Thaysen laid out a plan for the genomics ...
At the Crossroads: Illumina Settlement Reflects the Intersection of Cybersecurity and Healthcare Law
On July 31, the U.S. Department of Justice (DOJ) announced a settlement in United States ex rel. Lenore v. Illumina, Inc, the first case in which underlying cybersecurity issues formed the basis of a ...
Genetic sequencing company Illumina (ILMN) has had a rough few years. It has battled activist investors, faced off with the Federal Trade Commission, and, most recently, agreed to a $9.8 million ...
With Illumina's divestiture of GRAIL, the company will improve its operating expenses, since GRAIL reported significant losses while it was part of Illumina. The global DNA sequencing market is ...
Less than two years after Boulder-based biotech firm SomaLogic Inc. merged with Standard BioTools Inc. (Nasdaq: LAB), Illumina Inc. (NASDAQ: ILMN) has inked a deal to absorb SomaLogic’s business in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results